A significant amount of progress has been made in improving the treatment of lung cancer and patient outcomes. However, a number of disparities that can have an impact on these persist, including those affecting lung cancer screening. Lung cancer screening is an essential step toward effective treatment and improved survival, but its success depends on…
Efforts should be made to address patient concerns about clinical trial participation.
Black and Hispanic patients were more likely to have COVID-19 but less likely to have an increase in telehealth visits.
Even with an “exponential growth” of URM students, “faculty diversity would remain static well into the next 50 years.”
Historical trend of increased incidence in Blacks versus Whites disappeared in men, reversed in women.
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.
Frequencies of genomic alterations in current therapeutic targets similar for AFR, EUR men.
Time from diagnosis to definitive surgery is twice as long on average for black versus white patients.
Disparities for disease severity not seen at diagnosis, meaning postdiagnosis factors may affect outcome.
Racial and ethnic disparities have emerged among patients with cancer and COVID-19, with black and Hispanic populations experiencing disproportionality high mortality rates.
